Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron for Medical Expulsive Therapy
NCT02744430Phase 2Completed
- Sponsor
- Baylor College of Medicine
- Start
- Jul 2017
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mirabegron in ureteral calculus, sponsored by Baylor College of Medicine. Started Jul 2017; status: completed.
02
Drugs
mirabegron
03
Conditions
ureteral calculus
Beyond the preview
Go deeper on NCT02744430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02744430.